NCT06479616 A Long-term Follow-up Study in Participants Who Received CS-101
| NCT ID | NCT06479616 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Beta-Thalassemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 5 participants |
| Start Date | 2024-06-18 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5 participants in total. It began in 2024-06-18 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)
Eligibility Criteria
Inclusion Criteria: * Participants (or his or her legally appointed and authorized representative or guardian) must sign and date informed consent form (ICF) and, where applicable, an assent form * Participants must have received CS-101 infusion in last IIT study Exclusion Criteria: * There are no exclusion criteria
Contact & Investigator
Xiaowen Zhai, M.D.
PRINCIPAL INVESTIGATOR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT06479616 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 17 Years, studying Beta-Thalassemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06479616 currently recruiting?
Yes, NCT06479616 is actively recruiting participants. Contact the research team at zhaixiaowendy@163.com for enrollment information.
Where is the NCT06479616 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06479616 clinical trial?
NCT06479616 is sponsored by Children's Hospital of Fudan University. The principal investigator is Xiaowen Zhai, M.D. at Children's Hospital of Fudan University. The trial plans to enroll 5 participants.